Gossamer Bio, Inc.
USD0.17
+0.00 (+2.07%)
CEO
Faheem Hasnain
IPO Date
2019-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.17
Prev. Close
$0.16
Day Low
$0.16
Day High
$0.17
52W Low
$0.14
52W High
$3.87
Market Cap
$0.04B
Volume
2.01M
| -3.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -286.5% | -57.6% | 3.38 | 5.94 | -1.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -1899.3% | -84.2% | 18.69 | 5.32 | -0.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -192.7% | -68.1% | 1.53 | 8.32 | -3.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -75.9% | -45.1% | 0.57 | 13.51 | -2.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -51.3% | -42.4% | 0.11 | 11.09 | -4.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 122.4% | -61.4% | 0.00 | 11.37 | -7.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 98.7% | -1521.6% | -0.88 | 0.35 | -65.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 67.5% | -138.3% | -0.33 | 0.42 | -1980.1 |
| -3.7 |
| 30 Sept 2025 | Q3 | 100.0% | -362.7% | 58.6% | -23.1% | -2.46 | 3.28 | -3.1 |
| 30 Jun 2025 | Q2 | 100.0% | -333.1% | 83.0% | -15.9% | -4.40 | 4.40 | -1.8 |
| 31 Mar 2025 | Q1 | 100.0% | -370.5% | 586.2% | -13.1% | -32.45 | 5.71 | -1.7 |
| 31 Dec 2024 | Q4 | 100.0% | -352.2% | -112.0% | -10.5% | 6.88 | 6.88 | -1.6 |
| 30 Sept 2024 | Q3 | 100.0% | -324.9% | -56.9% | -8.8% | 3.76 | 6.74 | -1.8 |
| 30 Jun 2024 | Q2 | 100.0% | 51.4% | 60.4% | 13.2% | 2.44 | 8.21 | 1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -156.9% | -16.2% | 7.82 | 7.13 | -1.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -76.7% | -15.4% | 3.38 | 5.94 | -1.1 |